Variant report
Variant | esv5934 |
---|---|
Chromosome Location | chr7:21450149-21451243 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182730541 | chr7:21450171-21450172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571877254 | chr7:21450221-21450222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188148551 | chr7:21450259-21450260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554598440 | chr7:21450260-21450261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560053128 | chr7:21450273-21450274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192627641 | chr7:21450358-21450359 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563659775 | chr7:21450374-21450375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116870133 | chr7:21450380-21450381 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557298756 | chr7:21450414-21450415 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553070049 | chr7:21450422-21450423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145925091 | chr7:21450467-21450468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs80353404 | chr7:21450469-21450470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528730403 | chr7:21450475-21450476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548778057 | chr7:21450502-21450503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568707057 | chr7:21450506-21450507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs367856849 | chr7:21450510-21450511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116055090 | chr7:21450524-21450525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549518419 | chr7:21450526-21450527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373683395 | chr7:21450532-21450533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182974340 | chr7:21450590-21450591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138772720 | chr7:21450602-21450603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78681530 | chr7:21450654-21450655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187561710 | chr7:21450710-21450711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564910093 | chr7:21450754-21450755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534556317 | chr7:21450819-21450820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192681842 | chr7:21450826-21450827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17144407 | chr7:21450834-21450835 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs116366356 | chr7:21450915-21450916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557100214 | chr7:21450924-21450925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs253426 | chr7:21450925-21450926 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs141816870 | chr7:21450927-21450928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567254659 | chr7:21450935-21450936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559913784 | chr7:21450936-21450937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs253427 | chr7:21450943-21450944 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs184558483 | chr7:21451024-21451025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546497396 | chr7:21451109-21451110 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562266813 | chr7:21451120-21451121 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148872727 | chr7:21451142-21451143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376967545 | chr7:21451149-21451150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs253428 | chr7:21451151-21451152 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs377117327 | chr7:21451157-21451158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551225588 | chr7:21451183-21451184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571043293 | chr7:21451216-21451217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532010501 | chr7:21451240-21451241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 16773561 | CNVD |
Schizophrenia | 19546859 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:21450000-21450200 | Enhancers | Small Intestine | intestine |
2 | chr7:21450000-21451800 | Enhancers | Thymus | Thymus |
3 | chr7:21450000-21454200 | Enhancers | Fetal Thymus | thymus |
4 | chr7:21450200-21451800 | Weak transcription | Small Intestine | intestine |
5 | chr7:21450400-21454400 | Enhancers | Primary T cells fromperipheralblood | blood |
6 | chr7:21450600-21454000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr7:21451000-21453400 | Enhancers | Primary T cells from cord blood | blood |
8 | chr7:21451000-21453800 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
9 | chr7:21451200-21453200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
10 | chr7:21451200-21453800 | Enhancers | GM12878-XiMat | blood |